Medicare Enrolled

Dr. Ana Van Der Wall, MD

Hematology · Bradenton, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3630 MANATEE AVE W, Bradenton, FL 34205
9417921881
In practice since 2009 (17 years)
NPI: 1265672018 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Van Der Wall from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Van Der Wall? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Van Der Wall

Dr. Ana Van Der Wall is a hematology in Bradenton, FL, with 17 years in practice. Based on federal Medicare data, Dr. Van Der Wall performed 264,925 Medicare services across 4,183 unique beneficiaries.

Between the years covered by Open Payments, Dr. Van Der Wall received a total of $6,587 from 69 pharmaceutical and/or device companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Van Der Wall is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 10% volume in FL$ $6,587 industry payments

Medicare Practice Summary

Medicare Utilization ↗
264,925
Medicare services
Top 10% in FL for hematology
4,183
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~15,584 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)64,260$0$4
Iron infusion (Injectafer)62,250$1$3
Pembrolizumab injection (Keytruda)28,200$43$137
Denosumab injection (Prolia/Xgeva)20,880$18$51
Filgrastim injection (Zarxio) for white blood cells18,120$0$2
Anti-nausea injection (aprepitant)15,340$1$5
Paclitaxel chemotherapy injection13,681$0$2
Epoetin alfa injection (Procrit) for anemia12,630$6$23
Abatacept infusion (Orencia)5,925$34$140
Injection, eflapegrastim-xnst, 0.1 mg3,960$26$116
Blood draw (venipuncture)2,927$8$9
Complete blood count (CBC) with differential2,766$8$29
Dexamethasone injection (steroid)2,730$0$3
Anti-nausea injection (Aloxi/palonosetron)2,050$1$28
Office visit, established patient (30-39 min)1,175$97$339
Drug injection, under skin or into muscle957$10$69
Anti-nausea injection (ondansetron/Zofran)912$0$9
Injection of additional new drug or substance into vein777$12$61
Administration of chemotherapy into vein, 1 hour or less633$96$378
Office visit, established patient (20-29 min)611$63$239
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less462$47$189
Infusion into a vein for hydration, each additional hour318$10$42
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less294$22$84
Injection, methylprednisolone sodium succinate, up to 40 mg272$3$11
Infusion, normal saline solution , 1000 cc227$2$7
Office visit, established patient, complex (40-54 min)225$136$474
Injection, cisplatin, powder or solution, 10 mg224$2$13
Injection, diphenhydramine hcl, up to 50 mg205$1$3
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg198$1$6
Injection, carboplatin, 50 mg189$2$41
Injection, zoledronic acid, 1 mg153$6$69
Administration of chemotherapy into vein, each additional hour150$21$79
Administration of additional new drug or substance into vein, 1 hour or less138$49$178
Automated urinalysis115$2$8
New patient office visit, complex (60-74 min)111$162$585
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle109$25$89
Injection, magnesium sulfate, per 500 mg108$1$2
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional106$16$59
Infusion into a vein for hydration, 31-60 minutes93$23$156
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour91$15$56
Administration of additional new drug or substance into vein using push technique82$42$170
Injection of drug or substance into vein72$28$156
Leuprolide acetate (for depot suspension), 7.5 mg69$135$562
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle35$52$206
Red blood count automated, with additional calculations28$5$20
Red blood count, automated test25$4$10
Hospital follow-up visit, high complexity25$91$285
New patient office visit (30-44 min)17$79$298
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
50.6% high complexity
46.3% medium
3.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,587
Total received (2018-2024)
Avg $941/year across 7 years
Bottom 46% in FL for hematology
69
Companies
352
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,587 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,308
2023
$1,206
2022
$820
2021
$1,479
2020
$916
2019
$453
2018
$406

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$812
Celgene Corporation
$447
PFIZER INC.
$348
Novartis Pharmaceuticals Corporation
$321
AstraZeneca Pharmaceuticals LP
$299
Janssen Biotech, Inc.
$280
Daiichi Sankyo Inc.
$275
Gilead Sciences, Inc.
$257
GENZYME CORPORATION
$252
Merck Sharp & Dohme LLC
$251
Astellas Pharma US Inc
$237
Amgen Inc.
$205
Kite Pharma, Inc.
$203
BeiGene USA, Inc.
$147
Genentech USA, Inc.
$128
Incyte Corporation
$126
Seagen Inc.
$119
ARRAY BIOPHARMA INC
$104
Rigel Pharmaceuticals, Inc.
$102
Merck Sharp & Dohme Corporation
$98
Takeda Pharmaceuticals U.S.A., Inc.
$92
Epizyme, Inc.,
$84
Lilly USA, LLC
$83
Pharmacyclics LLC, An AbbVie Company
$81
PUMA BIOTECHNOLOGY, INC.
$75
Dendreon Pharmaceuticals LLC
$65
ABBVIE INC.
$59
Dova Pharmaceuticals
$59
Stemline Therapeutics Inc.
$46
Eisai Inc.
$44
Bayer HealthCare Pharmaceuticals Inc.
$43
Karyopharm Therapeutics Inc.
$40
Myovant Sciences Inc.
$40
AbbVie Inc.
$38
GlaxoSmithKline, LLC.
$38
Servier Pharmaceuticals LLC
$37
SpringWorks Therapeutics, Inc.
$36
Taiho Oncology, Inc.
$36
Sobi, Inc
$33
Heron Therapeutics, Inc.
$30
PharmaEssentia USA Corporation
$30
Myriad Genetic Laboratories, Inc.
$29
Jazz Pharmaceuticals Inc.
$26
TerSera Therapeutics LLC
$25
Regeneron Healthcare Solutions, Inc.
$25
JAZZ PHARMACEUTICALS INC.
$24
Pharmacyclics LLC, an AbbVie Company
$24
Deciphera Pharmaceuticals Inc.
$22
AbbVie, Inc.
$21
Ipsen Biopharmaceuticals, Inc
$20
ADC Therapeutics America, Inc.
$20
Alnylam Pharmaceuticals Inc.
$18
SANOFI-AVENTIS U.S. LLC
$18
Mirati Therapeutics, Inc.
$18
Blueprint Medicines Corporation
$18
TG Therapeutics, Inc.
$18
Epizyme, Inc.
$17
Sirtex Medical Inc
$17
Sumitomo Pharma America, Inc.
$15
MEDIVATION FIELD SOLUTIONS LLC
$14
Exelixis Inc.
$13
Acceleron Pharma, Inc.
$13
SERVIER PHARMACEUTICALS LLC
$13
NanoString Technologies, Inc.
$12
Acrotech Biopharma LLC
$12
Teva Pharmaceuticals USA, Inc.
$12
AMAG Pharmaceuticals, Inc.
$12
Aurobindo Pharma USA, Inc.
$11
Veracyte, Inc.
$0
Top 3 companies account for 24.4% of total payments
Associated products mentioned in payments ›
AFINITOR · ALIMTA · AYVAKIT · Alecensa · Aliqopa · Avastin · BENDEKA · BESREMI · BLENREP · BRAFTOVI · BRUKINSA · CALQUENCE · CERDELGA · CEREZYME · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Erleada · FERAHEME · FRUZAQLA · GAZYVA · GIVLAARI · HEMADY · IBRANCE · IMBRUVICA · INREBIC · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MONJUVI · MYRISK · NERLYNX · NINLARO · Nplate · Nubeqa · OGSIVEO · ONCASPAR · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PLUVICTO · PROSIGNA ASSAY · PROVENGE · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · Reblozyl · SARCLISA · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Sustol · TAGRISSO · TASIGNA · TAZVERIK · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · UKONIQ · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Yescarta · ZEJULA · ZEPZELCA · Zevalin · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a hematology in Bradenton?
Compare hematologys in the Bradenton area by procedure volume, costs, and industry payment transparency.
Browse hematologys nearby

Geographic Context

Hematologys within 10 mi
19
Per 100K population
4.6
County median income
$75,792
Nearest hospital
SUNCOAST BEHAVIORAL HEALTH CENTER
4.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Van Der Wall is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Van Der Wall experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Van Der Wall performed 64,260 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Van Der Wall receive payments from pharmaceutical companies?
Yes. Dr. Van Der Wall received a total of $6,587 from 69 companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Van Der Wall's costs compare to other hematologys in Bradenton?
Dr. Van Der Wall's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Van Der Wall) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →